IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v13y2016i6p545-d71089.html
   My bibliography  Save this article

Clinical Significance of Long Non-Coding RNA CASC8 rs10505477 Polymorphism in Lung Cancer Susceptibility, Platinum-Based Chemotherapy Response, and Toxicity

Author

Listed:
  • Lei Hu

    (Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China
    Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha 410078, China)

  • Shu-Hui Chen

    (Department of Oncology, Changsha Central Hospital, Changsha 410006, China)

  • Qiao-Li Lv

    (Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China
    Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha 410078, China)

  • Bao Sun

    (Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China
    Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha 410078, China)

  • Qiang Qu

    (Department of Pharmacy, Xiangya Hospital, Central South University, Changsha 410008, China)

  • Chong-Zhen Qin

    (Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Central South University, Zhengzhou 450052, China)

  • Lan Fan

    (Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China
    Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha 410078, China)

  • Ying Guo

    (Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China
    Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha 410078, China)

  • Lin Cheng

    (State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou 510060, China)

  • Hong-Hao Zhou

    (Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China
    Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha 410078, China)

Abstract

Long non-coding RNA (lncRNA) CASC8 rs10505477 polymorphism has been identified to be related to risk of many kinds of cancers, such as colorectal cancer, gastric cancer, and invasive ovarian cancer, and it may be involved in the prognosis of gastric cancer patients who have received platinum-based chemotherapy after surgical treatment. So far, there is no study investigating the clinical significance of lncRNA CASC8 rs10505477 in lung cancer susceptibility and treatment. In this study, we genotyped 498 lung cancer patients and 213 healthy control subjects to explore the correlation between the rs10505477 polymorphism and lung cancer risk in a Chinese population. Among the 498 patients, 467 were selected for the chemotherapy response and toxicity study. We found that the single nucleotide polymorphisms (SNP) rs10505477 was greatly related to lung cancer risk in male and adenocarcinoma subgroups in recessive model (adjusted OR = 0.51, 95%CI = 0.29–0.90, p = 0.02; adjusted OR = 0.52, 95%CI = 0.30–0.89, p = 0.02, respectively). It was also closely correlated with platinum-based chemotherapy response in dominant model (adjusted OR = 1.58, 95%CI = 1.05–2.39, p = 0.03). Additionally, we observed that CASC8 rs10505477 polymorphism was significantly relevant to severe hematologic toxicity in non-small-cell lung cancer (NSCLC) subgroup in dominant model (adjusted OR = 0.59, 95%CI = 0.35–0.98, p = 0.04) and in additive model (adjusted OR = 0.62, 95%CI = 0.43–0.90, p = 0.01). Furthermore, it was found that rs10505477 polymorphism was greatly associated with gastrointestinal toxicity in SCLC and cisplatin subgroups in dominant model (adjusted OR = 7.82, 95%CI = 1.36–45.07, p = 0.02; adjusted OR = 1.94, 95%CI = 1.07–3.53, p = 0.03, respectively). Thus, lncRNA CASC8 rs10505477 could serve as a possible risk marker for diagnosing lung cancer, and could be used to forecast the response and toxicity of platinum-based treatment in lung cancer patients.

Suggested Citation

  • Lei Hu & Shu-Hui Chen & Qiao-Li Lv & Bao Sun & Qiang Qu & Chong-Zhen Qin & Lan Fan & Ying Guo & Lin Cheng & Hong-Hao Zhou, 2016. "Clinical Significance of Long Non-Coding RNA CASC8 rs10505477 Polymorphism in Lung Cancer Susceptibility, Platinum-Based Chemotherapy Response, and Toxicity," IJERPH, MDPI, vol. 13(6), pages 1-12, May.
    • Handle: RePEc:gam:jijerp:v:13:y:2016:i:6:p:545-:d:71089
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/13/6/545/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/13/6/545/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Rajnish A. Gupta & Nilay Shah & Kevin C. Wang & Jeewon Kim & Hugo M. Horlings & David J. Wong & Miao-Chih Tsai & Tiffany Hung & Pedram Argani & John L. Rinn & Yulei Wang & Pius Brzoska & Benjamin Kong, 2010. "Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis," Nature, Nature, vol. 464(7291), pages 1071-1076, April.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Feng Zhi & Qiang Wang & Lian Xue & Naiyuan Shao & Rong Wang & Danni Deng & Suinuan Wang & Xiwei Xia & Yilin Yang, 2015. "The Use of Three Long Non-Coding RNAs as Potential Prognostic Indicators of Astrocytoma," PLOS ONE, Public Library of Science, vol. 10(8), pages 1-14, August.
    2. Yixiao Zhu & Chengmei Huang & Chao Zhang & Yi Zhou & Enen Zhao & Yaxin Zhang & Xingyan Pan & Huilin Huang & Wenting Liao & Xin Wang, 2023. "LncRNA MIR200CHG inhibits EMT in gastric cancer by stabilizing miR-200c from target-directed miRNA degradation," Nature Communications, Nature, vol. 14(1), pages 1-19, December.
    3. Ye-Lin Liang & Yuan Zhang & Xi-Rong Tan & Han Qiao & Song-Ran Liu & Ling-Long Tang & Yan-Ping Mao & Lei Chen & Wen-Fei Li & Guan-Qun Zhou & Yin Zhao & Jun-Yan Li & Qian Li & Sheng-Yan Huang & Sha Gong, 2022. "A lncRNA signature associated with tumor immune heterogeneity predicts distant metastasis in locoregionally advanced nasopharyngeal carcinoma," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    4. Gayani Batugedara & Xueqing M. Lu & Borislav Hristov & Steven Abel & Zeinab Chahine & Thomas Hollin & Desiree Williams & Tina Wang & Anthony Cort & Todd Lenz & Trevor A. Thompson & Jacques Prudhomme &, 2023. "Novel insights into the role of long non-coding RNA in the human malaria parasite, Plasmodium falciparum," Nature Communications, Nature, vol. 14(1), pages 1-19, December.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:13:y:2016:i:6:p:545-:d:71089. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.